Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001085967 | SCV000554396 | likely benign | Atrioventricular septal defect 5 | 2024-12-08 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000514657 | SCV000609833 | likely benign | not provided | 2017-03-10 | criteria provided, single submitter | clinical testing | |
Personalized Diabetes Medicine Program, |
RCV000664151 | SCV000787603 | likely benign | Monogenic diabetes | 2017-12-21 | criteria provided, single submitter | research | ACMG criteria: PP3 (6 predictors), BP4 (5 predictors), BS2 (139 hets in gnomAD)=Likely benign |
Clinical Genomics, |
RCV003884550 | SCV004698143 | uncertain risk allele | Pancreatic hypoplasia-diabetes-congenital heart disease syndrome | criteria provided, single submitter | research | Potent mutations in GATA6 gene are associated with neonatal diabetes, decreased insulin production due to pancreatic aplasia or hypoplasia. Also associated with isolated cardiac abnormalities in children, like atrial septal defects.However no sufficient evidence is found to ascertain the role of this particular variant rs149569288 yet. | |
Laboratory of Diagnostic Genome Analysis, |
RCV000514657 | SCV002036735 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000514657 | SCV002037459 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003925331 | SCV004749016 | likely benign | GATA6-related disorder | 2022-05-02 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |